---

| Wednesday, February 14th | 0 comments

Herantis Pharma opening recruitment in Parkinson’s disease study in Helsinki and Lund based on favorable first CDNF safety assessment

https://herantis.com/press_releases/herantis-pharma-opening-recruitment-in-parkinsons-disease-study-in-helsinki-and-lund-based-on-favorable-first-cdnf-safety-assessment/

---